FDA Brief

Warning letters Drugs

FDA warning letter to

Amazon.com, Inc.

High riskIssued Oct 1Posted Oct 6Center for Drug Evaluation and Research (CDER)

FDA warns Amazon over nine unapproved drugs sold on its website for genital herpes and STI symptoms.

What happened

FDA reviewed labeling of products purchased on www.amazon.com in July 2026 and found nine products marketed for genital herpes or STI symptoms. FDA says Amazon introduced or delivered the products into interstate commerce through Fulfillment by Amazon. FDA says the products are unapproved new drugs because they are intended to treat disease and have no approved applications.

What FDA found

  1. The products are drugs because their labeling says they relieve or treat genital herpes or STI symptoms.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128
  2. The products are new drugs not generally recognized as safe and effective, and FDA has not approved applications for them.

    FD&C Act sections 201(p) and 505(a), 21 U.S.C. 321(p) and 355(a)
  3. Introducing or delivering these unapproved drugs into interstate commerce violates the law.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  4. Herstat GST claims relief from genital sores, which goes beyond the allowed uses in OTC Monograph M017.

    FD&C Act section 505G; OTC Monograph M017
  5. Some products labeled homeopathic do not qualify for FDA's homeopathic guidance because they contain lemongrass, which is not listed in the Homeopathic Pharmacopeia of the United States.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); Homeopathic Pharmacopeia of the United States

What FDA wants

Send a written response within 15 business days to FDAAdvisory@fda.hhs.gov with specific corrective steps, preventive measures, root-cause explanation, and supporting documents, referencing 736006.

Who should pay attention

  • online marketplaces and fulfillment providers
  • sellers of OTC or homeopathic STI products
  • brands relying on Amazon Fulfillment by Amazon

This is a summary. Read the original letter on fda.gov.

Amazon.com, Inc.'s FDA history

  1. Amazon.com, Inc.

    FDA warned Amazon that three creams sold and shipped through Fulfillment by Amazon are unapproved new drugs for phimosis and balanitis.

    High risk
  2. Amazon.com, Inc.

    Nonprescription/OTC

  3. Amazon.com, Inc.

    Unapproved New Drugs/Misbranded

  4. Amazon.com, Inc.

    Finished Pharmaceuticals/Unapproved New Drugs

  5. Amazon.com, Inc.

    Finished Pharmaceuticals/Unapproved New Drug/Misbranded

  6. Amazon.com, Inc.

    Unapproved New Drugs/Misbranded

  7. Amazon.com, Inc

    Unapproved New Drugs/Misbranded

  8. Amazon.com, Inc.

    Finished Pharmaceuticals/Unapproved New Drug/Misbranded

  9. Amazon.com, Inc.

    Finished Pharmaceuticals/Unapproved New Drug

Full company page

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk